Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Mesenchymal stem cell therapy for laryngotracheal stenosis: A systematic review of preclinical studies

Research output: Contribution to journalReviewpeer-review

  1. Dancing with atrial fibrillation - How arrhythmia affects everyday life of family members: A qualitative study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Insulin resistance genetic risk score and burden of coronary artery disease in patients referred for coronary angiography

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Genetic markers of abdominal obesity and weight loss after gastric bypass surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. COVID-19 infection rate among tertiary referral center otorhinolaryngology healthcare workers

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Manuscript title: the maxillary swing approach - the first Scandinavian experience

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Sequelae of Major Trauma Patients with Maxillofacial Fractures

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Laryngotracheal stenosis (LTS) can be either congenital or acquired. Laryngeal stenosis is most often encountered after prolonged intubation. The mechanism for stenosis following intubation is believed to be hypertrophic scarring. Mesenchymal stem cells (MSCs) therapy has shown promising results in regenerative medicine. We aimed to systematically review the literature on MSC therapy for stenosis of the conductive airways.

METHODS: PubMed, EMBASE, Google Scholar and the Cochrane Library were systematically searched from January 1980-January 2017 with the purpose of identifying all studies addressing the effect of MSC therapy on the airway. We assessed effect on inflammation, fibrosis, and MSC as a component in tissue engineering for treating defects in the airway.

RESULTS: We identified eleven studies (n = 256 animals) from eight countries evaluating the effect of MSCs as a regenerative therapy in the upper airways. The studies indicate that MSC therapy may lead to a more constructive inflammatory response as well as support tissue regeneration.

CONCLUSION: There may be a favorable effect of MSCs in inhibiting inflammation and as a component in tissue engineering. Given the heterogeneous nature of the included animal studies, any clear conclusion regarding the effect of tracheal stenosis in human subjects cannot be drawn. The included preclinical studies are however encouraging for further research.

Original languageEnglish
JournalP L o S One
Volume12
Issue number9
Pages (from-to)e0185283
ISSN1932-6203
DOIs
Publication statusPublished - 2017

    Research areas

  • Animals, Fibrosis, Humans, Larynx, Mesenchymal Stem Cell Transplantation, Tracheal Stenosis, Treatment Outcome, Journal Article, Review

ID: 52367498